GENEVA, Switzerland, September 26 /PRNewswire/ --

- CHMP Issued Positive Opinion Recommending Marketing Authorization of Kuvan(R) for the Treatment of hyperphenylalaninemia in Patients With phenylketonuria or BH4 Deficiency

POMPEY, France, September 26 /PRNewswire/ --

- Custom Chiral Separation Using Preparative Chromatography Eases and Speeds up Process Development; Rapidly and Efficiently Producing the Required Amount of Compounds for Early Development Phases While Being Cost Efficient at Industrial Scale

Novasep, a global leader in advanced separation technologies, has recently added a state-of-the-art cGMP pilot scale continuous chromatography unit in its Chasse sur Rhône (France) facility. This ensures cost efficient separations of kilograms to tens of kilograms of pure enantiomer for clinical supplies.

STOCKHOLM, Sweden, September 26 /PRNewswire/ -- Nanoradio today announced that its "Always On WiFi"(TM) solution has been commercially launched inside the world's first 3G UMA phone. The same "Always On WiFi"(TM) solution was also recently launched in a 2.5G UMA phone. The two phones, P250 and P270, will both be released by Samsung in multiple countries in Europe, opening up a new world of multimedia services to the UMA operator customer base. The P270 is the first device on the market that combines UMA and 3G network technology.

PARIS, September 26 /PRNewswire/ --

- State-of-the-art medical training center in Paris designed to advance standard of patient care

Boston Scientific Corporation (NYSE: BSX) today announced the grand opening of the International Institute for Therapy Advancement in Paris. The Institute is dedicated to providing world-class training and education to help healthcare professionals advance the standard of patient care. The 3,000 square-meter facility offers the latest in modern medical training and current clinical science focused on cardiac and vascular therapies. The grand opening, hosted by Boston Scientific senior executives, was attended by leading European electrophysiologists.

EVRY, France, September 26 /PRNewswire/ -- Novagali Pharma, a French Laboratory specialized in ophthalmology announces today it has secured EUR15 million in a new financing round with the participation of the historical Company investors.

Thanks to this new contribution Novagali Pharma will continue to develop its high potential projects:

- The commercialization in France and abroad of its first marketable product, Cationorm(R), indicated for the treatment of dry eye symptoms,

KAKAMEGA, Kenya, September 26 /PRNewswire/ --

- Voluntary HIV Counseling and Testing Campaign Provides Affordable and Efficient Approach to Preventing Disease Identified

An important new approach to fighting malaria, diarrhoeal disease and HIV among adult men and women aged 15-49 has successfully been demonstrated for the first time in the Western Kenyan district of Kakamega in Lurambi division.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080925/NYTH149 )